Atlas Trials

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Clinical trial NCT02474537 · COMPLETED

Trial details

NCT number
NCT02474537
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2015-06-12
Primary completion
2017-08-14
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.